The impact of dry weight calculation by measuring serum sodium pre- dialysis on some of hemodialysis complications

The effect of ultra filtration adjustment based on dry weight calculation by measuring serum sodium pre- dialysis on some of hemodialysis complications

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015042318649N2

Enrollment

Registered

2015-09-09

Start date

2015-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal failure. Chronic kidney disease, stage 5

Interventions

Intervention 1: In the intervention group: The blood sodium levels will be measured pre - dialysis to calculate patients' dry weight and then ultrafiltration will be set based on dry weight and dialy

Treatment - Other

In the intervention group: The blood sodium levels will be measured pre - dialysis to calculate patients' dry weight and then ultrafiltration will be set based on dry weight and dialysis will be don

In the control group: Dry weight will be determined in routine way and accordingly the ultrafiltration rate will be adjusted and patient will be dialysis for 12 weeks.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: history of dialysis more than one year; Age of 18-65 years; be able to communicate verbally; lack of syndrome of inappropriate antidiuretic hormone secretion and diabetes insipidus; lack of human immunodeficiency virus infection; lack of mechanical ventilation; do not have heart and liver failure; lack of an overactive adrenal gland; do not use serotonin inhibitor drugs; do not use anti-spasmodic and anti-hypertensive drugs four hours before of dialysis. Exclusion criteria: The patient's unwillingness to continue for cooperating during the study; disruption of blood flow through the fistula.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood pressure disorders. Timepoint: At one hours interval during dialysis. Method of measurement: Blood pressure is measured using a sphygmomanometer.;Muscle cramps. Timepoint: At one hours interval during dialysis. Method of measurement: Using check list.;Nausea and vomiting. Timepoint: At one hours interval during dialysis. Method of measurement: Using check list.;Fatigue. Timepoint: At the end of dialysis. Method of measurement: Using Visual scale.	—

Measure

Time frame

Blood pressure disorders. Timepoint: At one hours interval during dialysis. Method of measurement: Blood pressure is measured using a sphygmomanometer.;Muscle cramps. Timepoint: At one hours interval during dialysis. Method of measurement: Using check list.;Nausea and vomiting. Timepoint: At one hours interval during dialysis. Method of measurement: Using check list.;Fatigue. Timepoint: At the end of dialysis. Method of measurement: Using Visual scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Saadatmand

Golestan University of Medical Sciences

saadatmand.sara61@gmil.com+98 17 3242 6900

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026